Your session is about to expire
← Back to Search
Novel Oral Polio Vaccine Type 1 (nOPV1) for Polio
Study Summary
This trial is testing the safety of two new oral polio vaccines. The main goal is to see if they are safe for humans. A secondary goal is to see if the vaccines cause immunogenicity (an immune response) and if the virus sheds in the feces.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Is this clinical trial a pioneering endeavor in its field?
"Currently, 3 nOPV1 trials are taking place in 11 cities over 4 countries. The earliest of these studies began in 2020 and was sponsored by NeuroActiva, Inc., involving 3600 participants. Subsequently, 22 other related clinical investigations have been carried out since then."
Are geriatric individuals excluded from this investigation?
"The requirements for this medical trial dictate that individuals enrolling must be within the 18-45 age range. Additionally, there are 7 trials specifically focusing on underage patients and 2 studies dedicated to those 65 years of age or above."
Are there any past trials that have featured Novel Oral Polio Vaccine Type 1 (nOPV1)?
"The Coronavirus Research Institute- Testing Site was the initial site of exploration for Novel Oral Polio Vaccine Type 1 (nOPV1) in 2020. There have been 22 finished studies since then and 3 active ones, mainly based out of Lebanon, New hampshire."
Is enrollment still open for this research endeavor?
"This clinical trial is no longer admitting applicants, having last been amended on August 24th 2022. Prospective participants who are interested in trials for poliomyelitis or Novel Oral Polio Vaccine Type 1 (nOPV1) should note that there are currently 9 and 3 studies respectively recruiting patients."
Who is qualified to join this research program?
"This study is searching for 205 individuals aged 18 to 45 with poliomyelitis. It is mandatory that these participants be male or female, abide by any hormonal injections prescribed, and practice abstinence from sexual intercourse."
What is the enrollment size of this investigation?
"This research initiative is no longer recruiting participants. It was published on March 26th 2021 and last updated August 24th 2022. Those seeking other medical studies can look into the 9 trials related to poliomyelitis or 3 studies pertaining to Novel Oral Polio Vaccine Type 1 (nOPV1) that are still actively searching for subjects."
Share this study with friends
Copy Link
Messenger